Companion Dx Partnerships, M&A Deals Help Spur IVD Market Growth – PWC Report
This article was originally published in The Gray Sheet
Executive Summary
A report from PricewaterhouseCoopers suggests the in vitro diagnostics market will see accelerated growth next year due in part to a surge in companion diagnostics partnerships and M&A deals.
You may also be interested in...
The Clinical Laboratory Of The Future: Can Technology Fill The Gaps?
Clinical laboratories in the US and Europe are facing pressure from all sides as budget cuts and staffing shortages compete with a growing demand for ever-more-sophisticated lab tests to serve an aging population. As a result, lab directors are seeking innovative ways to improve efficiency and do more with less, and those goals are driving innovation in technology-based solutions such as laboratory automation and informatics. These solutions are increasingly becoming integrated into the total laboratory process – encompassing not only sample analysis, but also up- and downstream workflows – paving the way for the fully integrated, automated lab of the future.
News In Brief
Transcatheter valve registry launched. Qiagen cuts costs. FCC grants RF spectrum for Medical Micropower Networks. More industry news.
CDRH’s Mansfield Addresses Upcoming Drug/Dx Co-Development Guidance
Either an IND or an IDE will be sufficient for companion diagnostic studies, a CDRH diagnostics official clarified last week. That is among the issues that will be addressed in an upcoming co-development draft guidance.